Tribune News Service
Chandigarh, May 13
The Punjab authorities on Thursday determined to join the COVAX facility alliance for global sourcing and procurement of Covid vaccines at one of the best value, changing into the primary state to take such a step amid vaccine scarcity within the nation.
The resolution was taken throughout the Cabinet assembly, which additionally accepted the acquisition of Covaxin for industrial employees, for whose vaccination the business has expressed willingness to pay.
The state authorities has to this point ordered solely Covishield vaccine for the 18-44 age group, however with this resolution, decks have been cleared to place orders for Covaxin too.
Reviewing the vaccination standing and availability within the state, the Cabinet mentioned it was obligatory to supply vaccine globally.
Since the COVAX facility gives one of the best costs, the state ought to make an try to join the identical for procuring vaccines from the worldwide markets, it determined.
The suggestion for becoming a member of the COVAX was given to the Cabinet by Dr Gagandeep Kang, who heads the Punjab Expert Group on Vaccination.
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative geared toward equitable entry to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the World Health Organisation.
In a short presentation, Health Secretary Hussan Lal knowledgeable the Cabinet that of the 30 lakh Covishield doses ordered by the state authorities, the Serum Institute of India had to this point confirmed 4.29 lakh, of which 1 lakh doses had been acquired.
He additional disclosed that some Central authorities establishments and industrial institutions had been requesting for early vaccination of their workforce.
Given the scarcity of vaccines, he identified that sure states had been floating global tenders to import the identical.
The well being secretary additional apprised the Cabinet that for the 45+ age group, the final tranche of Covishield vaccine (1,63,710 doses) was acquired on May 9, taking the full to 42,48,560. As many as 3,45,000 doses got to the armed forces, whereas the full vaccination utilization stood at 39,03,560.
For Covaxin within the 45+ class, the final tranche of vaccine acquired was of 75,000 doses (6 May, 2021), taking the full acquired to 4,09,080, of which utilisation until date was 3,52,080, leaving availability of solely 57,000 now.